EFSD/Boehringer Ingelheim European Research Programme on “Multi-System Challenges in Diabetes”

2020

Remy Burcelin: INSERM - Toulouse, France
Molecular control of insulin resistance by the host to microbiota crosstalk

Ulf Eriksson: Karolinska Institute - Stockholm, Sweden
VEGF-B signalling in diabetic complications of liver, kidney and heart

Shai Fuchs: The Sheba Fund for Health Services and Research - Ramat-Gan, Israel
Regulation of dysglycaemia and hepatosteatosis by the gut L-cell hepatic stellate cell axis

Sophie Lestavel: Université de Lille - France
Role of intestinal epithelial FXR in the Non Alcoholic Fatty Liver Disease complication of type 2 diabetes

Marcelina Parrizas: Consorcio Centro de Investigación Biomédica en Red, M.P. (CIBER) - Barcelona, Spain
Experimental modulation of exosomal miRNA targets for the treatment of diabetes

Allan Vaag: Steno Diabetes Center Copenhagen - Gentofte, Denmark
Subcutaneous adipocyte pertubations and ectopic fat disposition in men with low birth weight

Rob Wust: Vrije University Amsterdam - Netherlands
NOX2 as the nexus between exercise intolerance and mitochondrial dysfunction in type 1 diabetes

2019

Daniel Cuthbertson: University of Liverpool – United Kingdom
Metabolic and multi-organ effects of low-calorie diet in prediabetes and NAFLD

Ben Jones: Imperial College London – United Kingdom
Understanding the tissue-specific effects of biased GLP-1 receptor agonism in type 2 diabetes

Andreas F. H. Pfeiffer: Charité Universitaetsmedizin Berlin - Germany
FAIR - Fasting-Induced Immune-metabolic Remission of Diabetes

Romano Regazzi: University of Lausanne - Switzerland
Exosome-mediated RNA transfer between insulin target tissues and pancreatic beta cells

Jennifer Rieusset: INSERM U1060 - Lyon, France
Splanchnic triumvirate crosstalk through the dynamic regulation of MAMs by nutrients and GLP1

Maria Rohm: Helmholtz Center Munich - Neuherberg, Germany
A TBL1/TBLR1-dependent adipose tissue/beta cell axis controlling metabolism and glucose homeostasis